Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Open Offer

2 Nov 2018 07:00

RNS Number : 1133G
Imaginatik PLC
02 November 2018
Β 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Prior to publication, certain information contained within this Announcement was deemed to constitute inside information for the purposes of Article 7 of MAR

Β 

Imaginatik plc

("Imaginatik" or "the Company")

Β 

Launch of Underwritten Open Offer

Β 

On 26 October 2018, Imaginatik plc (AIM: IMTK) plc, the #1 ranked leader in corporate innovation management was pleased to announce an underwritten Open Offer. Today, 2 November it will post a document to Qualifying Shareholders (the "Circular") regarding an Open Offer of 22,961,687 New Ordinary Shares at 1.1 pence ("the Issue Price") to raise up to approximately Β£252,578 (before expenses). The Issue Price represents a discount of 41.33 per cent to the closing price on theΒ 31 October 2018.

Β 

Qualifying Shareholders will have a Basic Entitlement of 6 Open Offer Share for every 9 Existing Ordinary Shares held and will also have the opportunity to apply for additional shares under the Excess Application Facility.

Β 

Β 

Background to, and reasons for the Open Offer

Β 

On 26 October 2018 the Company announced a series of measures designed to restore the trading of the Company's shares on AIM, to strengthen the finances of the Company, and to provide a stable and robust basis for the future development of the Company's operations.

Β 

The series of measures announced on the 26 October 2018 included a placing of 14,545,455 new ordinary shares of 0.002 pence each (the "Placing") in the capital of the Company, at a price of 1.1p (the "Placing Price"), representing approximatelyΒ 29.7Β per cent of the enlarged issued ordinary share capital of the Company, withΒ Eight Capital Partners Plc ("Eight Capital"), an investment vehicle listed on the NEX Exchange Growth Market.

Β 

The Company has also issuedΒ Β£90,000Β of new, unsecured, convertible loan notes ("CLNs") to Eight Capital. The CLNs have a term of three years and an annual coupon of 7.5 per cent.Β 

Β 

The funds raised from the Open Offer together with the funds raised as part of the Placing announced on 26 October 2018 will partly be used to repay a loan and to provide additional working capital.

Β 

Effects of the Open Offer

Β 

Upon Admission, and assuming full take up of the Open Offer Entitlements, the Enlarged Issued Share Capital is expected to be 71,949,673 Ordinary Shares. On this basis, the New Ordinary Shares will represent approximately 31.91 per cent. of the Company's Enlarged Issued Share Capital.

Β 

Following the issue of the New Ordinary Shares pursuant to the Open Offer, assuming full take up of the Open Offer Entitlements, Qualifying Shareholders who do not take up any of their Open Offer entitlements will suffer a dilution of 31.91 per cent. to their interests in the Company.

Β 

The Directors have concluded that proceeding with the Open Offer is the most suitable option available to the Company for raising additional funds through the issue of New Ordinary Shares and that issuing the New Ordinary Shares at a discount is fair and reasonable so far as all existing Shareholders are concerned.

Β 

Β 

Β 

Β 

Β 

OPEN OFFER STATISTICS

Β 

Number of Existing Ordinary Shares in issue at the date of this document

48,987,986

Number of Existing Ordinary Shares in issue at the Record Date

34,442,531

Issue Price per New Ordinary Share

1.1 pence

Open Offer Entitlement

6 Open Offer Shares

for every 9 Existing

Ordinary Shares

Number of Open Offer Shares*

Β 22,961,687

Open Offer Shares as a percentage of the Enlarged Issued Share Capital*

31.91 per cent.

Proceeds of the Open Offer

Β£252,578.56

Enlarged Issued Share Capital*

71,949,673

ISIN for Open Offer Entitlements

GB00BD3S3T18

ISIN for Excess Open Offer Entitlements

GB00BD3S3S01

ISIN for Existing ordinary Shares and, following Admission, the New

GB00BFMDJC60

Ordinary Shares

Β 

* Assuming take-up in full of the Open Offer by Qualifying Shareholders.

Β 

Β 

Settlement and dealing

Β 

In due course application will be made for the Open Offer Shares to be admitted to trading on AIM and Admission is expected to become effective and that dealings will commence at 8.00 a.m. on 28 November 2018.

Β 

The Open Offer Shares will rank, pari passu, in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued. It is expected that CREST accounts will be credited with entitlements to the New Ordinary Shares as soon as practicable after 8.00 a.m. on the day of Admission and that share certificates (where applicable) will be despatched as soon as practicable after Admission.

Β 

Β 

Underwriting Commitment

Β 

On 1 November 2018, Imaginatik and Peterhouse entered into an Underwriting Commitment under which Peterhouse has agreed severally to procure subscribers for, or, failing which, that Peterhouse shall introduce investors who themselves shall subscribe for (in proportion to their underwriting commitment), New Ordinary Shares to the extent not taken up under the Open Offer in each case at the Issue Price.

Β 

Β 

Recommendation

Β 

The Directors consider the Open Offer to be in the best interests of the Company and its Shareholders as a whole. As the Company is in a close period the Directors are not able to trade in Imaginatik shares including participation in the Open Offer at this stage, if the Company ceases to be in a close period within the Open Offer timetable it is their intention to participate in the Open Offer.

Β 

The Directors of the Company accept responsibility for the content of this announcement.

Β 

Capitalised terms not defined in this Application Form shall have the same meanings as set out in the Circular.

Β 

A copy of the Circular post to Qualifying Shareholders together with the application form can be downloaded from the Company's website: www.imaginatik.com

Β 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Β 

Open Offer Record Date

6.00 p.m. on 26 October 2018

Announcement of the Open Offer

2 November 2018

Date of this document and of the posting of this document, and Application Forms

2 November 2018

Date Existing Ordinary Shares marked 'ex-entitlement' by the London Stock Exchange

8.00 a.m. on 2 November 2018

Open Offer Entitlements and Excess Open Offer Entitlements credited to CREST stock accounts of Qualifying CREST Shareholders

8.00 a.m. on 5 November 2018 or as soon possible thereafter

Recommended latest time and date for requesting withdrawal of Open Offer Entitlements and Excess Open Offer Entitlements from CREST

4.30 p.m. on 21 November 2018

Latest time and date for depositing Open Offer Entitlements and Excess Open Offer Entitlements into CREST

3.00 p.m. on 23 November 2018

Latest time and date for splitting Application Forms (to satisfy bona fide market claims in relation to Open Offer Entitlements only)

3.00 p.m. on 23 November 2018

Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer or settlement of the relevant CREST instructions (as appropriate)

11.00 a.m. on 26 November 2018

Admission and commencement of dealings in the New Ordinary Shares on AIM expected to commence

8.00 a.m. on 28 November 2018

Expected time and date on which CREST accounts to be credited with New Ordinary Shares in uncertificated form

On or after 8.00 a.m. on

28 November 2018

Expected date for despatch of definitive share certificates in respect of New Ordinary Shares to be issued in certificated form

By 5 December 2018

Β 

Notes:

Β 

1. Reference to times in this document is to London time unless otherwise stated.

2. Each of the times and dates above are indicative only and are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified by the Company to the Shareholders by announcement through a Regulatory Information Service.

Β 

Β 

- ENDS -

Β 

For further information, please contact:

Imaginatik plc

Angus Forrest CEO

Β 

Via Alma

WH Ireland - Nominated Adviser

Mike Coe / Chris Savidge

Β 

Tel: 0117 945 3472

Peterhouse Capital Limited - Broker

Eran Zucker / Lucy Williams

Β 

Tel: +44 (0) 20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

Β 

Tel: +44 (0) 20 8004 4218

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IOEVFLFBVFFXFBX
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.